Premium
Inclusion of patients in clinical trial analysis: the intention‐to‐treat principle
Author(s) -
Heritier Stephane R,
Gebski Val J,
Keech Anthony C
Publication year - 2003
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2003.tb05627.x
Subject(s) - clinical trial , inclusion (mineral) , medicine , library science , family medicine , sociology , social science , computer science
The Medical Journal of Australia ISSN: 0025-729X 20 October 2003 179 8 438-440 ©The Medical Journal of Australia 2003 www.mja.com.au EBM: Trials on Trial DETERMINING THE SAMPLE OF PARTICIPANTS to be analysed is a crucial step in reporting clinical trials. For such analyses, the gold standard is the “intention-to-treat” principle. The question of which participants are included in the analysis appears as Item 16 of the CONSORT statement (Box 1).1